Education
About Us
Working with TipRanks
Follow Us
Irhythm Technologies (IRTC)
:IRTC
IRTC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$55.92 - $168.32
Previous CloseN/A
Volume94.23K
Average Volume (3M)483.34K
Market Cap
$5.15B
Enterprise Value$5.11B
Total Cash (Recent Filing)$545.54M
Total Debt (Recent Filing)$734.74M
Price to Earnings (P/E)―
Beta0.82
Next Earnings
Oct 30, 2025EPS Estimate
-0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding32,127,760
10 Day Avg. Volume616,420
30 Day Avg. Volume483,341
Financial Highlights & Ratios
PEG Ratio2.45
Price to Book (P/B)30.94
Price to Sales (P/S)4.75
P/FCF Ratio-92.07
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue7.78
Enterprise Value/Gross Profit11.15
Enterprise Value/Ebitda-78.15
Forecast
1Y Price Target
$175.40Price Target Upside9.39% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Bulls Say, Bears Say
Bulls Say
Guidance And MomentumManagement raised guidance by about $30 million due to stronger-than-expected performance, and shares are up as much as 14% on the updates.
Market ExpansionThe company has gained market share in the Zio AT segment and continues to retain significant business from past competitor disruptions.
Sales PerformanceSales beat expectations by the widest margin seen since 2022, with sales coming in $12 million ahead of the Street.
Bears Say
Pricing PressureAlthough the proposed payment rate for Zio AT is a positive surprise, past years have seen relatively large cuts, creating concerns over future pricing stability.
Regulatory ComplianceWhile the company completed most regulatory remediation plans, the ongoing need to manage compliance can impact future operations and costs.
Regulatory RisksThe proposed payment rates for Zio AT mobile cardiac telemetry are subject to change with the final rule, expected in November, posing potential uncertainty.
Irhythm Technologies News
IRTC FAQ
What was Irhythm Technologies’s price range in the past 12 months?
Irhythm Technologies lowest stock price was $55.92 and its highest was $168.32 in the past 12 months.
What is Irhythm Technologies’s market cap?
Irhythm Technologies’s market cap is $5.15B.
When is Irhythm Technologies’s upcoming earnings report date?
Irhythm Technologies’s upcoming earnings report date is Oct 30, 2025 which is in 83 days.
How were Irhythm Technologies’s earnings last quarter?
Irhythm Technologies released its earnings results on Jul 31, 2025. The company reported -$0.44 earnings per share for the quarter, beating the consensus estimate of -$0.492 by $0.052.
Is Irhythm Technologies overvalued?
According to Wall Street analysts Irhythm Technologies’s price is currently Undervalued.
Does Irhythm Technologies pay dividends?
Irhythm Technologies does not currently pay dividends.
What is Irhythm Technologies’s EPS estimate?
Irhythm Technologies’s EPS estimate is -0.33.
How many shares outstanding does Irhythm Technologies have?
Irhythm Technologies has 32,127,760 shares outstanding.
What happened to Irhythm Technologies’s price movement after its last earnings report?
Irhythm Technologies reported an EPS of -$0.44 in its last earnings report, beating expectations of -$0.492. Following the earnings report the stock price went up 17.684%.
Which hedge fund is a major shareholder of Irhythm Technologies?
Currently, no hedge funds are holding shares in IRTC
Irhythm Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$175.40 (9.39% Upside)
$175.40 (9.39% Upside)
Blogger Sentiment
Bullish
IRTC Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 530.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $529.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
114.22%
12-Months-Change
Fundamentals
Return on Equity
-91.13%
Trailing 12-Months
Asset Growth
4.88%
Trailing 12-Months
Company Description
Irhythm Technologies
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
IRTC Company Deck
IRTC Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call was largely positive with strong revenue growth, record new account openings, international expansion, and improved EBITDA margins. Despite ongoing FDA remediation costs and being slightly free cash flow negative, the company demonstrated strong performance and optimism for the future.View all IRTC earnings summariesIRTC Stock 12 Month Forecast
Average Price Target
$175.40
▲(9.39% Upside)
Technical Analysis
Ownership Overview
1.86% Insiders
38.86% Mutual Funds
0.25% Other Institutional Investors
43.13% Public Companies and
Individual Investors